Event Type
Disclosure
Voluntary
Variant
8-K
Regulation FD Disclosure. MiMedx Group, Inc. (the “Company”) is expected to participate in the Bank of America Securities 2025 Healthcare Conference on May 13,
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Investor Slide Presentation dated May 13, 2025 104 The cover page from